All treatments
Treatment
Standard disease-directed therapy clinical trials
2 indexed studies · 2 currently recruiting
- RecruitingPHASE1
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
This study is testing a new medicine, INCA036978, for people with certain blood conditions called myeloproliferative neoplasms (MPNs). We want to see if it's safe, what dose works best, and if it can be combined with other treatments.
For: Myeloproliferative NeoplasmsUnited States · Australia · Belgium - RecruitingPHASE1
A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms
This study is looking at a new medicine called INCB160058 for people with certain blood conditions called Myeloproliferative Neoplasms (MPN). Researchers want to see if it's safe, how well people tolerate it, and how it moves through the body.
For: Myeloproliferative NeoplasmsUnited States · Canada · France